144 related articles for article (PubMed ID: 30101722)
1. Anticancer Mechanism of Lobaplatin as Monotherapy and in Combination with Paclitaxel in Human Gastric Cancer.
Hua S; Kong X; Chen B; Zhuang W; Sun Q; Yang W; Liu W; Zhang Y
Curr Mol Pharmacol; 2018; 11(4):316-325. PubMed ID: 30101722
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
Xie CY; Xu YP; Jin W; Lou LG
Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
[TBL] [Abstract][Full Text] [Related]
3. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
[TBL] [Abstract][Full Text] [Related]
4. Lobaplatin inhibits growth of gastric cancer cells by inducing apoptosis.
Yin CY; Lin XL; Tian L; Ye M; Yang XY; Xiao XY
World J Gastroenterol; 2014 Dec; 20(46):17426-33. PubMed ID: 25516654
[TBL] [Abstract][Full Text] [Related]
5. Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki.
Li X; Ran L; Fang W; Wang D
Biomed Pharmacother; 2014 Apr; 68(3):291-7. PubMed ID: 24239273
[TBL] [Abstract][Full Text] [Related]
6. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro.
Dai HY; Liu L; Qin SK; He XM; Li SY
Biomed Pharmacother; 2011 Jun; 65(3):137-41. PubMed ID: 21612887
[TBL] [Abstract][Full Text] [Related]
7. Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.
Wu Q; Qin SK; Teng FM; Chen CJ; Wang R
J Hematol Oncol; 2010 Oct; 3():43. PubMed ID: 21034513
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin induces G
Chen MJ; Cheng AC; Lee MF; Hsu YC
J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
He J; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
[TBL] [Abstract][Full Text] [Related]
10. Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion.
Li Y; Liu B; Yang F; Yu Y; Zeng A; Ye T; Yin W; Xie Y; Fu Z; Zhao C
Biomed Pharmacother; 2016 Oct; 83():1239-1246. PubMed ID: 27565846
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.
Zhou Z; Jiang H; Xia J; Zhang J
Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992
[TBL] [Abstract][Full Text] [Related]
12. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
[TBL] [Abstract][Full Text] [Related]
13. Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal.
Chen L; Cao H; Yu C; Feng Y
Fundam Clin Pharmacol; 2018 Oct; 32(5):548-557. PubMed ID: 29733466
[TBL] [Abstract][Full Text] [Related]
14. Preclinical activity of lobaplatin as a single agent and in combination with taxanes for ovarian carcinoma cells.
Sun X; Lou LG; Sui DH; Wu XH
Asian Pac J Cancer Prev; 2014; 15(22):9939-43. PubMed ID: 25520132
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.
Liu N; Tian H; Zhang G; Sun N; Wang S
Med Oncol; 2021 Nov; 39(1):16. PubMed ID: 34837558
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of imrecoxib combined with lobaplatin on tumor growth and lymph node metastasis of human lung cancer xenografts in nude mice].
Wang DC; Wang LC; Wang LJ; Chen G; Zhao YX; Zhao ZF; Li YH
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):340-5. PubMed ID: 27188605
[TBL] [Abstract][Full Text] [Related]
17. [Artesunate inhibits proliferation of glioblastoma cells by arresting cell cycle].
Weng X; Zhu SQ; Cui HJ
Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(4):772-778. PubMed ID: 29600654
[TBL] [Abstract][Full Text] [Related]
18. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
[TBL] [Abstract][Full Text] [Related]
19. Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro.
Engel JB; Martens T; Hahne JC; Häusler SF; Krockenberger M; Segerer S; Djakovic A; Meyer S; Dietl J; Wischhusen J; Honig A
Anticancer Drugs; 2012 Apr; 23(4):426-36. PubMed ID: 22314264
[TBL] [Abstract][Full Text] [Related]
20. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
Harstrick A; Bokemeyer C; Scharnofkse M; Hapke G; Reile D; Schmoll HJ
Cancer Chemother Pharmacol; 1993; 33(1):43-7. PubMed ID: 8269588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
